JIM CARMICAL: Open Payments
NPI 1194145607 · MONTICELLO, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$411 in 22 payments from 8 companies in 2025. Trend: 2023 $884 · 2024 $681 · 2025 $411
Food & beverage: $411
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $232 |
| AstraZeneca Pharmaceuticals LP | 2 | $41 |
| PFIZER INC. | 2 | $34 |
| Exact Sciences Corporation | 2 | $33 |
| Lundbeck LLC | 1 | $20 |
| Novo Nordisk Inc | 1 | $19 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $16 |
| Axsome Therapeutics, Inc. | 1 | $16 |
Products named: QULIPTA, UBRELVY, VRAYLAR, BREZTRI, NURTEC ODT, REXULTI, Wegovy, The Cologuard Plus Collection Kit.
Industry payments across AR — which companies pay providers there.
